{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:33:59Z","timestamp":1791077639243,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.pupt.2010.03.005","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T08:22:58Z","timestamp":1269246178000},"page":"324-326","source":"Crossref","is-referenced-by-count":18,"title":["Impact of infusion method on amikacin serum levels in humans"],"prefix":"10.1016","volume":"23","author":[{"given":"N.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"D\u00e9caudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lannoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Broucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Poret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.pupt.2010.03.005_bib1","first-page":"47","article-title":"Once-daily versus multiple-daily dosing of aminoglycosides","volume":"7","author":"Craig","year":"1995","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.pupt.2010.03.005_bib2","first-page":"367","article-title":"Accuracy of tobramycin delivery by four i.v. infusion methods","volume":"7","author":"Pleasants","year":"1988","journal-title":"Clin Pharm"},{"key":"10.1016\/j.pupt.2010.03.005_bib3","first-page":"374","article-title":"Effect of four intravenous infusion methods on tobramycin pharmacokinetics","volume":"7","author":"Pleasants","year":"1988","journal-title":"Clin Pharm"},{"key":"10.1016\/j.pupt.2010.03.005_bib4","first-page":"328","article-title":"In vivo accuracy of gravity-flow i.v. infusion systems","volume":"42","author":"Crass","year":"1985","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.pupt.2010.03.005_bib5","first-page":"1090","article-title":"Regulating intravenous fluid flow: controller versus clamps","volume":"36","author":"Ziser","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.pupt.2010.03.005_bib6","first-page":"427","article-title":"Peripheral intravenous infusions. Reduction of morbidity owing to an electronic controller of infusion flow rate","volume":"13","author":"Zazzo","year":"1984","journal-title":"Presse Med"},{"key":"10.1016\/j.pupt.2010.03.005_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pupt.2010.03.005_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(84)90358-9","article-title":"Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia","volume":"77","author":"Moore","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2010.03.005_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1179\/joc.1996.8.6.457","article-title":"Efficacy and safety of once-daily amikacin in combination with ceftazidime in critically ill adults with severe gram-negative infections","volume":"8","author":"Fayed","year":"1996","journal-title":"J Chemother"},{"issue":"Suppl. C","key":"10.1016\/j.pupt.2010.03.005_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/27.suppl_C.91","article-title":"Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections","volume":"27","author":"Beaucaire","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pupt.2010.03.005_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jac\/28.5.753","article-title":"A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients","volume":"28","author":"Marik","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.pupt.2010.03.005_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/jcrc.2003.50003","article-title":"A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes","volume":"18","author":"Bacopoulou","year":"2003","journal-title":"J Crit Care"},{"key":"10.1016\/j.pupt.2010.03.005_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cpt1977213362","article-title":"Kinetic model for gentamicin dosing with the use of individual patient parameters","volume":"21","author":"Sawchuk","year":"1977","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.pupt.2010.03.005_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003088-200140110-00002","article-title":"Individualizing aminoglycoside dosage regimens after therapeutic drug monitoring; simple or complex pharmacokinetic methods?","volume":"40","author":"Tod","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.pupt.2010.03.005_bib15","first-page":"143","article-title":"Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin","volume":"5","author":"Burton","year":"1986","journal-title":"Clin Pharm"},{"key":"10.1016\/j.pupt.2010.03.005_bib16","series-title":"Applied clinical pharmacokinetics","first-page":"93","article-title":"The aminoglycoside antibiotics","author":"Bauer","year":"2001"},{"issue":"3","key":"10.1016\/j.pupt.2010.03.005_bib17","first-page":"247","article-title":"[Adaptive control of therapeutics using amikacin in very old patients: retrospective analysis of efficacy and toxicity] article in French","volume":"42","author":"Grillot","year":"1994","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.pupt.2010.03.005_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9343(96)80074-X","article-title":"Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients","volume":"101","author":"Koo","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.pupt.2010.03.005_bib19","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1001\/jama.248.23.3122","article-title":"Wide interpatient variations in gentamicin dose requirements for geriatric patients","volume":"248","author":"Zaske","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2010.03.005_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.39.2.545","article-title":"Aminoglycoside dosing weight correction factors for patients of various body sizes","volume":"39","author":"Traynor","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pupt.2010.03.005_bib21","first-page":"24","article-title":"Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm","volume":"35","author":"Debord","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pupt.2010.03.005_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2515\/therapie\/2009009","article-title":"Burdin de Saint Martin\u00a0J, Maire P, Ducher M. [Pharmacocin\u00e9tique de l\u2019amikacine chez l\u2019adulte: une h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 qui remet en cause le calcul de la dose bas\u00e9 sur le poids] article in French","volume":"64","author":"Bourguignon","year":"2009","journal-title":"Th\u00e9rapie"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553910000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553910000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T11:52:05Z","timestamp":1544615525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553910000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1094553910000271"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2010.03.005","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}